IT Conference & User Group Meeting has record attendance

The 13th international PAS-X User Group Meeting took place from 13 to 14 October 2011 in Lueneburg, Germany, with a record attendance. On the invitation of Werum Software & Systems , almost 200 pharmaceuticals experts from approximately 20 countries exchanged their thoughts and ideas on the use of the PAS-X production management system by Werum in the production of pharmaceutical products.

“Building on Manufacturing Execution as our main area of expertise, we are continuing to expand our range of products and services for all areas of Manufacturing IT,” said Hartmut Krome, Executive Board Member at Werum Software & Systems AG. “Based on our pronounced experience in the industry, we can offer the pharmaceuticals sector and related industries sustainable solutions for optimally supporting all production processes – from development to packaging.”

User reports, including those from Janssen Biologics, Novo Nordisk and Sandoz, provided the conference participants with insights into how manufacturing execution systems are implemented in practice and what challenges they face in the process.

The PAS-X User Forum, in which many Werum customers are organized in special interest groups, presented its results. The forum supplies decisive impulses for the continuous further development of PAS-X and other industry requirements.

As part of a special evening event on 13 October 2011, Werum celebrated the grand opening of a new office building on the company grounds in Lueneburg. The cube-shaped building became necessary due to the increased number of employees. Werum currently employs approximately 450 people at nine sites worldwide.


About Eoin Ó Riain

Sé Read-out iris uaithoibríoch, ionstraim agus stiúradh na hÉireann agus an "Signpost" a áit ar an idirlín! Read-out is Ireland's journal of automation, instrumentation and control and the Instrumentation Signpost is it's web presence.
This entry was posted in Event and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s